987 / 1851
Selection of
best CT
to give concurrently with RT
Use of
targeted agents
concurrent with chemo-RT
Role of
Rx dose intensification
and use of any
advanced technology RT tools
Good PS Stage III NSCLC:
Lack of Evidence